Literature DB >> 2444169

[Our experience with a hexane extract of Serenoa repens in the treatment of benign prostatic hypertrophy].

J Ollé Carreras.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2444169

Source DB:  PubMed          Journal:  Arch Esp Urol        ISSN： 0004-0614            Impact factor:   0.436


× No keyword cloud information.
  2 in total

Review 1.  Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.

Authors:  G L Plosker; R N Brogden
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

2.  Distribution study of radioactivity in rats after oral administration of the lipido/sterolic extract of Serenoa repens (Permixon) supplemented with [1-14C]-lauric acid, [1-14C]-oleic acid or [4-14C]-beta-sitosterol.

Authors:  G Chevalier; P Benard; H Cousse; T Bengone
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jan-Mar       Impact factor: 2.441
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.